Detalhe da pesquisa
1.
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.
Gastroenterology
; 156(8): 2313-2329.e7, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30836093
2.
Impact of Cytomegalovirus Infection on the Outcome of Patients With Cirrhosis: A Preliminary Study.
J Clin Gastroenterol
; 53(3): 236-241, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30383568
3.
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents.
PLoS Pathog
; 10(5): e1004128, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24830295
4.
Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C.
Gut
; 64(3): 483-94, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24848265
5.
Loss of hepatitis B surface antigen in a real-life clinical cohort of patients with chronic hepatitis B virus infection.
Liver Int
; 35(1): 130-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25145784
6.
Hepatitis C virus envelope glycoprotein signatures are associated with treatment failure and modulation of viral entry and neutralization.
J Infect Dis
; 207(8): 1306-15, 2013 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23335805
7.
Impact of anti-HDV reflex testing at HBs antigen positive discovery in a single center France: Support for primary HDV screening in France.
J Clin Virol
; 171: 105650, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38350177
8.
Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies.
Gastroenterology
; 143(1): 223-233.e9, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22503792
9.
A poxvirus vaccine is safe, induces T-cell responses, and decreases viral load in patients with chronic hepatitis C.
Gastroenterology
; 141(3): 890-899.e1-4, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21699798
10.
Endoscopic placement of fully covered self expanding metal stents for management of post-operative foregut leaks.
J Minim Access Surg
; 8(4): 118-24, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23248437
11.
Safety and Antiviral Activity of EGFR Inhibition by Erlotinib in Chronic Hepatitis C Patients: A Phase Ib Randomized Controlled Trial.
Clin Transl Gastroenterol
; 13(6): e00492, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35363627
12.
Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with COVID-19.
Clin Res Hepatol Gastroenterol
; 46(5): 101894, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35227956
13.
Characteristics and care of chronic hepatitis C treated with direct-acting antivirals in migrants.
Eur J Gastroenterol Hepatol
; 34(6): 664-670, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34974466
14.
Changes in the profile and therapeutic care of people who use drugs with HCV mono-infection: a retrospective study between 2015 and 2019 from a monocentric tertiary referent center in France.
Eur J Gastroenterol Hepatol
; 34(5): 560-566, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35421021
15.
Fatty acid composition of the erythrocyte membrane and risk of hepatocellular carcinoma in cirrhotic patients.
Aliment Pharmacol Ther
; 52(9): 1503-1515, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32780481
16.
Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion.
Gastroenterology
; 135(5): 1719-1728.e1, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18718838
17.
Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy.
J Med Virol
; 81(12): 2029-35, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19856464
18.
Dietary components modulate the risk of hepatocellular carcinoma in cirrhotic patients.
Nutr Res
; 61: 82-94, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30683441
19.
Interleukin-32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance.
Hepatol Commun
; 3(9): 1205-1220, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31497742
20.
Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.
Hepatology
; 46(6): 1722-31, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18000990